Restarting Zepbound After Illness: Timing, Symptoms, and Next Steps

Can you take Zepbound when you have a stomach bug?

Food poisoning and a stomach virus can cause symptoms that overlap with Zepbound's gastrointestinal adverse effects. The name you give the illness does not establish the cause of ongoing vomiting or abdominal pain. The prescribing information warns that gastrointestinal reactions can lead to dehydration and acute kidney injury. [1]

Tell the prescriber what is happening before making a restart decision: whether you can keep food and fluids down, when vomiting or diarrhea last occurred, and whether symptoms are improving. If you cannot keep fluids down, feel faint, or have severe or persistent abdominal pain, seek prompt medical assessment. Trouble breathing or swelling of the face or throat requires emergency care.

Do not use a single drink, a urine-color check, or a fixed symptom-free interval as proof that another injection is safe. Those observations can be useful to report, but they do not replace the clinical assessment.

Figure 1

Severe stomach and bowel reactions in the Zepbound weight trials, by dose

Severe stomach and bowel reactions in the Zepbound weight trials, by doseBar chart of severe gastrointestinal adverse reactions in the pooled weight trials: 1% on placebo, 1.7% on 5 mg, 2.5% on 10 mg and 3.1% on 15 mg. Acute kidney injury was reported in 0.5% of Zepbound-treated patients and 0.2% of placebo-treated patients.Placebo1.0%Zepbound 5 mg1.7%Zepbound 10 mg2.5%Zepbound 15 mg3.1%0%1%2%3%Patients with a severe gastrointestinal reaction (%)
Severe stomach and bowel reactions in the Zepbound weight trials, by doseBar chart of severe gastrointestinal adverse reactions in the pooled weight trials: 1% on placebo, 1.7% on 5 mg, 2.5% on 10 mg and 3.1% on 15 mg. Acute kidney injury was reported in 0.5% of Zepbound-treated patients and 0.2% of placebo-treated patients.Placebo1.0%Zepbound 5 mg1.7%Zepbound 10 mg2.5%Zepbound 15 mg3.1%0%1%2%3%Patients with a severe gastrointestinal reaction (%)
Share of patients in the label's two pooled weight trials who had a gastrointestinal reaction graded severe. The label links these reactions, through dehydration, to acute kidney injury, which was reported in 0.5% of Zepbound-treated patients against 0.2% on placebo. The label asks for kidney monitoring when side effects could lead to fluid loss; it says nothing specific about vomiting or diarrhea caused by an illness. Source: Zepbound prescribing information, section 5.2, section 6.1, section 5.3 [1].
Show the numbers behind this chart
Severe stomach and bowel reactions in the Zepbound weight trials, by dose
Treatment groupSevere gastrointestinal adverse reactions (%)
Placebo1.0
Zepbound 5 mg1.7
Zepbound 10 mg2.5
Zepbound 15 mg3.1

What changes the restart decision?

SituationWhat to tell the care teamQuestion to settle before restarting
Vomiting, diarrhea, or food poisoningSymptom timing, fluid intake, last injection, and any urgent-care assessmentHas the illness resolved enough to resume treatment, and is another cause possible?
Cold, influenza, or COVID-19Whether eating, drinking, breathing, or daily function is affectedDoes this illness require any change to the existing treatment plan?
Hospitalization or a new diagnosisDischarge instructions, new medicines, kidney results if obtained, and doses missedWhich clinician owns the restart instruction?
Surgery or anesthesiaProcedure date, the team's hold instructions, recovery and oral intakeWhen does the procedural team want this medication resumed?
Several missed weeks after recoveryLast dose and strength, gap length, previous side effectsWhich restart dose and follow-up plan are appropriate now?

The table is a way to organize the call. It is not a dose calculator, and a particular illness duration does not select a dose.

Figure 2

Back from an illness: the questions that settle the next Zepbound injection

Decision diagram. First: if you still cannot keep food and fluids down, or have severe or lasting belly pain, get assessed before any injection; the label warns that fluid loss from vomiting or diarrhea can cause kidney problems and asks for kidney monitoring when it happens. Second: if insulin or a sulfonylurea was changed during the illness, the restart needs a joint plan, because these medicines with Zepbound raise the risk of low blood sugar. Third: if a procedure with anesthesia or deep sedation is planned, tell that team you use Zepbound, because it slows stomach emptying. Last: a single missed weekly dose follows the label's missed-dose timing once you are well; after several missed weeks the label names no restart dose, so ask for the dose and date in writing.
The order to work through before the next dose after a stomach bug, flu, another infection or a hospital stay. The label gives no illness-specific restart dose and no symptom-free waiting period, so the path ends with the prescriber's written plan rather than a calculation. Source: Zepbound prescribing information, Medication Guide, section 5.3, section 5.7 [1].
Text version of this diagram
  1. Are you keeping food and fluids down, without severe or lasting belly pain?
    • Not yet: Get assessed before the next injection. Fluid loss from vomiting or diarrhea can cause kidney problems, and the label asks for kidney monitoring when it happens.
    • Yes: Check your other medicines next.
  2. Was insulin or a sulfonylurea changed or stopped during the illness?
    • Yes: Agree one restart plan for both: with Zepbound these medicines raise the risk of low blood sugar, and their doses may need lowering.
    • No: Go on to the doses you missed.
  3. Procedure coming up: Tell the anesthesia team you use Zepbound. It slows stomach emptying, which matters for anesthesia or deep sedation.
  4. How many weekly doses did the illness cost you?
    • One: Once you are well enough to inject, the label's ordinary missed-dose timing applies.
    • Several: The label names no restart dose for a longer gap. Ask the prescriber for the dose and date in writing.

Do you have to restart at a lower dose?

Sometimes a clinician may choose a lower dose after an interruption, but the current label does not publish an illness-specific dose-reduction ladder. Neither seven days of illness nor a particular amount of weight lost establishes that one or two dose steps should be removed. [1]

There is also no universal instruction to resume the old dose after a shorter illness. Prior tolerability, the length of the gap, continuing symptoms, and the reason treatment stopped all matter. Use the longer-gap Zepbound restart guide when more than one weekly dose has been missed.

Ask for the restart dose, injection date, and any later increase in writing. If the strength you have at home differs from the prescribed restart strength, check with the pharmacy. Do not improvise a smaller dose from a different presentation.

How long after vomiting or diarrhea should you wait?

The U.S. Zepbound label does not provide a universal 48-hour or 72-hour symptom-free restart rule. It also does not define a required volume of water that clears someone to inject. [1]

Instead of counting from the last symptom alone, describe whether eating and drinking have returned to normal for you, whether symptoms recur, and whether the illness required treatment. A person with kidney disease, a hospital admission, or another medicine that affects fluid balance may need a different assessment from someone recovering from a mild, brief illness.

If your own clinician has already given you a sick-day plan, follow that plan and contact the team if your recovery does not fit it. Do not replace it with a generic online schedule.

Restarting after surgery is a separate situation

Before a procedure, tell the anesthesia and procedural teams that you use Zepbound. Current multisociety guidance allows many patients to continue GLP-1 medicines before surgery, with additional measures or a different plan for people at higher risk. An automatic one-week hold for everyone is not the current approach. [2]

After the procedure, follow the team's restart instructions. Ask who will confirm the first dose and what to do if you cannot eat or drink normally. Preoperative advice is not clearance to restart during ongoing vomiting or an unresolved complication.

If the procedural team and prescribing team give different instructions, ask them to reconcile the plan before your next dose.

What if illness caused only one missed injection?

Once it is appropriate to resume, the ordinary missed-dose timing may still matter: the label uses a 4-day window and at least 3 days between injections. The single missed-dose guide gives examples. The important distinction is that the time window answers when a late dose fits the schedule; it does not answer whether you are well enough to take it.

For a longer interruption, a medication change, or treatment stopped because of a serious reaction, use the prescriber's specific instructions.

A message you can send your prescribing team

Use this as a starting point and fill in your own details:

My last Zepbound dose was [strength] on [date]. I missed [number] scheduled injections because of [illness or procedure]. My current symptoms are [symptoms], and I can [describe eating and drinking]. I was assessed at [clinic or hospital, if applicable], and my medicines changed as follows: [changes]. Please confirm whether I should resume, the dose and date, and when to contact you if symptoms return.

Include insulin or sulfonylurea treatment if relevant, since reduced intake and changes to glucose-lowering treatment need a coordinated plan. Do not independently stop or restart those medicines from instructions written for Zepbound. [1]

Frequently asked questions

Can I restart Zepbound after food poisoning?
Restart may be possible after recovery, but persistent vomiting, diarrhea, poor intake, or severe pain needs assessment. Ask the prescriber for the timing and dose rather than using a fixed step-down rule.
Do I drop two dose steps after a stomach bug?
The current Zepbound label gives no such rule. Illness duration alone does not determine the restart dose.
Can I restart after COVID-19?
The decision depends on recovery, current symptoms, medicines, and how many doses were missed. A COVID-19 diagnosis alone does not select a particular restart dose.
Does waiting 48 hours mean it is safe to inject?
Not by itself. The label has no universal 48-hour post-illness clearance rule. Follow the plan from the team managing your illness and Zepbound prescription.

References

  1. Eli Lilly and Company. Zepbound U.S. prescribing information, revised August 2026. Sections 2.1-2.3, 5.2-5.7 and 5.9. Prescribing information.
  2. American Society of Anesthesiologists. Drugs for Diabetes or Weight Loss: What To Know Before Surgery. Sections on continuing medication, individualized planning and risk factors before a procedure. Patient guidance.
Evidence overview for Restarting Zepbound After Illness: Timing, Symptoms, and Next Steps